Results 191 to 200 of about 17,163 (245)
Some of the next articles are maybe not open access.
Annals of Otology, Rhinology & Laryngology, 1978
A case of oral neomycin ototoxicity is presented, followed by a summary of known cases in the English literature. While it is known that neomycin is concentrated in the inner ear fluids, at the present time the biochemical basis of its ototoxic effect has not been definitively elucidated.
K M, Ward, F J, Rounthwaite
openaire +2 more sources
A case of oral neomycin ototoxicity is presented, followed by a summary of known cases in the English literature. While it is known that neomycin is concentrated in the inner ear fluids, at the present time the biochemical basis of its ototoxic effect has not been definitively elucidated.
K M, Ward, F J, Rounthwaite
openaire +2 more sources
Current practice of ototoxicity management across the United Kingdom (UK) [PDF]
International Journal of Audiology, 2018 OBJECTIVE: Effective management of patients diagnosed with ototoxicity is needed to reduce hearing and balance damage which affects communication and life quality.
Ghada Al-Malky
exaly +1 more source
Current Opinion in Otolaryngology & Head & Neck Surgery, 2007
To summarize mechanisms of ototoxicity associated with aminoglycoside antibiotics and discuss possible protective strategies.Studies in the past 15 years have demonstrated that aminoglycoside ototoxicity is mediated by an apoptotic form of cell death which employs caspase-dependent pathways. Reactive oxygen species have been demonstrated in the sensory
Mark Douglas, Rizzi, Keiko, Hirose
openaire +2 more sources
To summarize mechanisms of ototoxicity associated with aminoglycoside antibiotics and discuss possible protective strategies.Studies in the past 15 years have demonstrated that aminoglycoside ototoxicity is mediated by an apoptotic form of cell death which employs caspase-dependent pathways. Reactive oxygen species have been demonstrated in the sensory
Mark Douglas, Rizzi, Keiko, Hirose
openaire +2 more sources
Otolaryngologic Clinics of North America, 1993
The aminoglycoside antibiotics are active bactericidal agents used for the treatment of tuberculosis and gram-negative bacterial infections. Well over 2 million patients per year receive aminoglycosides; however, a major limitation to their use is ototoxicity (cochleotoxicity and vestibulotoxicity), nephrotoxicity, and neuromuscular blockade ...
C M, Henley, L P, Rybak
openaire +2 more sources
The aminoglycoside antibiotics are active bactericidal agents used for the treatment of tuberculosis and gram-negative bacterial infections. Well over 2 million patients per year receive aminoglycosides; however, a major limitation to their use is ototoxicity (cochleotoxicity and vestibulotoxicity), nephrotoxicity, and neuromuscular blockade ...
C M, Henley, L P, Rybak
openaire +2 more sources
Veterinary Clinics of North America: Small Animal Practice, 1994
This article describes the pathophysiology of ototoxic agents and contains a list of potential ototoxic agents including a list of animal species in which the toxicity has been documented or research studies performed.
openaire +2 more sources
This article describes the pathophysiology of ototoxic agents and contains a list of potential ototoxic agents including a list of animal species in which the toxicity has been documented or research studies performed.
openaire +2 more sources
Otolaryngology–Head and Neck Surgery, 1989
Neither otomycoses nor defects of the tympanic membrane are rare. In cases of fungal infection when the tympanic membrane is not intact, the possibility exists that antimycotic medication could enter the middle ear and diffuse into the cochlea via the round window.
R R, Marsh, L W, Tom
openaire +2 more sources
Neither otomycoses nor defects of the tympanic membrane are rare. In cases of fungal infection when the tympanic membrane is not intact, the possibility exists that antimycotic medication could enter the middle ear and diffuse into the cochlea via the round window.
R R, Marsh, L W, Tom
openaire +2 more sources
American Journal of Otolaryngology, 1986
The author participated in two prospective studies of patients receiving aminoglycoside antibiotics. In the first study, 54 patients received amikacin, and 54 received gentamicin. In the second study, 61 patients received gentamicin, 50 received netilmicin, and 52 received tobramycin.
openaire +2 more sources
The author participated in two prospective studies of patients receiving aminoglycoside antibiotics. In the first study, 54 patients received amikacin, and 54 received gentamicin. In the second study, 61 patients received gentamicin, 50 received netilmicin, and 52 received tobramycin.
openaire +2 more sources
Drugs of Today, 2003
Over the last 10 years new information has been published providing a better understanding of the risk factors, mechanism and prevention of aminoglycoside ototoxicity. The use of a higher dose and once-daily intravenous administration of aminoglycosides has shown clinical effectiveness with no increase in ototoxicity when compared to traditional ...
openaire +2 more sources
Over the last 10 years new information has been published providing a better understanding of the risk factors, mechanism and prevention of aminoglycoside ototoxicity. The use of a higher dose and once-daily intravenous administration of aminoglycosides has shown clinical effectiveness with no increase in ototoxicity when compared to traditional ...
openaire +2 more sources
International Journal of Andrology, 1987
Ototoxicity is one of the unwanted side effects of cisplatin treatment. The first sign of hearing loss usually appears 3–4 days after the drug administration and occurs primarily in the higher frequencies. One hundred and eighty‐six women treated with a moderate dose of cisplatin (50 mg/m2every 4 weeks) for gynaecological cancer were studied.
G, Laurell +3 more
openaire +2 more sources
Ototoxicity is one of the unwanted side effects of cisplatin treatment. The first sign of hearing loss usually appears 3–4 days after the drug administration and occurs primarily in the higher frequencies. One hundred and eighty‐six women treated with a moderate dose of cisplatin (50 mg/m2every 4 weeks) for gynaecological cancer were studied.
G, Laurell +3 more
openaire +2 more sources
Archives of Otolaryngology - Head and Neck Surgery, 1982
To the Editor .—I read with interest the article entitled "The Ototoxicity of Topically Applied Povidone-Iodine Preparations," by Morizono and Sikora that was published in the AprilArchives(1982;108:210-213). I am questioning some of the conclusions of the authors. Unfortunately, they do not totally describe the scrub being tested.
openaire +2 more sources
To the Editor .—I read with interest the article entitled "The Ototoxicity of Topically Applied Povidone-Iodine Preparations," by Morizono and Sikora that was published in the AprilArchives(1982;108:210-213). I am questioning some of the conclusions of the authors. Unfortunately, they do not totally describe the scrub being tested.
openaire +2 more sources